Majority of first-wave COVID-19 clinical trials have significant design shortcomings, study finds

Most of the registered clinical trials of potential treatments for COVID-19 underway as of late March were designed in ways that will greatly limit their value in understanding potential treatments, according to a new study.

Leave a Reply

Your email address will not be published.